Detalles de la búsqueda
1.
Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy.
Diab Vasc Dis Res
; 3(1): 39-44, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16784180
2.
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.
Diabetes Care
; 28(7): 1547-54, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15983299
3.
A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone.
Diabetes Care
; 25(4): 708-11, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11919129
4.
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.
Diabetes Care
; 30(10): 2458-64, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17595355
5.
Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes.
BMJ
; 326(7388): 528-9, 2003 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-12623912
Resultados
1 -
5
de 5
1
Próxima >
>>